Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
In this Phase I study, the primary objective is to investigate the safety and tolerability of SKI2670 after oral administration in healthy female subjects. And secondary objective is to investigate the pharmacokinetics and pharmacodynamics of SKI2670 after oral administration in healthy female subjects.
Epistemonikos ID: 7d0ea7fbdc1a2d3f7d62958dc261a7adb8026911
First added on: May 12, 2024